Loading...
FIEGE HEALTHCARE LOGISTICS GMBH — Gliclazide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #10 buyer for Gliclazide · $1.7M import value · 61 shipments · GERMANY · DGFT Verified
FIEGE HEALTHCARE LOGISTICS GMBH is the #10 importer of Gliclazide from India with $1.7M in import value and 61 verified shipments. FIEGE HEALTHCARE LOGISTICS GMBH holds a 0.7% market share in Gliclazide imports based in GERMANY. The company sources from 1 verified supplier across 26 formulations shipped to 1 country. Overall, FIEGE HEALTHCARE LOGISTICS GMBH imports 2 pharmaceutical products worth $2.8M across 2 therapeutic categories.
Verified from 61 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| LUPIN LIMITED | $1.7M | 61 | 100.0% |
FIEGE HEALTHCARE LOGISTICS GMBH sources Gliclazide from 1 verified Indian supplier based on 61 customs records. The primary supplier is LUPIN LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #10 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 8 | M/S. RANBAXY FARMACEUTICA LTDA : | BRAZIL | $2.4M | 48 | $50.0K |
| 9 | RANBAXY FARMACEUTICA LTDA : | BRAZIL | $2.3M | 76 | $29.8K |
| 10 | FIEGE HEALTHCARE LOGISTICS GMBH ★ | GERMANY | $2.2M | 61 | $36.2K |
| 6 | CENTRAL PHARMACEUTICAL JOINT STOCK | VIETNAM | $1.6M | 33 | $50.0K |
| 12 | TORRENT DO BRASIL LIMITEDA | BRAZIL | $1.6M | 58 | $27.9K |
FIEGE HEALTHCARE LOGISTICS GMBH ranks #10 among 643 Gliclazide importers from India. Average shipment value of $36.2K compared to the market average of $40.7K. The closest competitors by value are M/S. RANBAXY FARMACEUTICA LTDA : and RANBAXY FARMACEUTICA LTDA :.
Destination countries from 61 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $1.7M | 61 | 100.0% |
FIEGE HEALTHCARE LOGISTICS GMBH imports Gliclazide to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $1.7M.
| Formulation | Value | Shipments |
|---|---|---|
| GLICLAZIDE SANDOZ 30MG 30 NL GLICLAZIDE MODIFIED RELEASE TABLETS OTHERS-MEDICINE PUT UP FOR RETAIL SALE | $258.1K | 8 |
| GLICLAZIDE SANDOZ 30MG 30 NL GLICLAZIDEMODIFIED RELEASE TABLETS OTHERS-MEDICINE PUT UP FOR RETAIL SALE | $204.2K | 12 |
| GLICLAZIDE MR TAB 60MG 30 SANDOZ FRANCEGLICLAZIDE MR TABLETS OTHERS-MEDICINE PUT UP FOR RETAIL SALE | $180.3K | 5 |
| GLICLAZIDE MR TAB 60MG 90 SANDOZ FRANCEGLICLAZIDE MODIFIED RELEASE TABLETS OTHERS-MEDICINE PUT UP FOR RETAIL SALE | $151.1K | 6 |
| GLICLAZIDE MR TAB 60MG 90 SANDOZ FRANCE | $100.0K | 2 |
| GLICLAZIDE MR TAB 60MG 90 SANDOZ FRANCE GLICLAZIDE MODIFIED RELEASE TABLETS OTHERS-MEDICINE PUT UP FOR RETAIL SALE | $100.0K | 2 |
| GLICLAZIDE MR TAB 60MG 90 SANDOZ FRANCE GLICLAZIDE MODIFIED RELEASE TABLETS OTHERS MEDICINE PUT UP FOR RETAIL SALE | $100.0K | 2 |
What FIEGE HEALTHCARE LOGISTICS GMBH and other importers must comply with to import Gliclazide from India
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
India exported $26.2M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. FIEGE HEALTHCARE LOGISTICS GMBH imports $1.7M of this total, accounting for 0.7% of India's Gliclazide exports with 61 shipments from GERMANY. This is verified from 61 customs shipment records covering 26 distinct formulations.
FIEGE HEALTHCARE LOGISTICS GMBH's average Gliclazide order value is $28.3K per consignment, based on 61 shipments totaling $1.7M. FIEGE HEALTHCARE LOGISTICS GMBH is based in GERMANY and ranks #10 among all Gliclazide importers from India by value. The company sources from 1 verified supplier in India.
FIEGE HEALTHCARE LOGISTICS GMBH sources Gliclazide from 1 verified Indian supplier: LUPIN LIMITED ($1.7M, 100.0%). This is based on 61 customs records.
FIEGE HEALTHCARE LOGISTICS GMBH ranks #10 among 643 Gliclazide importers from India with a 0.7% market share. The top 3 importers are TORRENT DO BRASIL LTDA ($6.5M), MEDREICH PLC ($3.1M), M/S. RANBAXY FARMACEUTICA LTDA : ($2.4M). FIEGE HEALTHCARE LOGISTICS GMBH processed 61 shipments from GERMANY.
FIEGE HEALTHCARE LOGISTICS GMBH imports 2 products worth $2.8M. Beyond Gliclazide, top products include Exemestane. View the complete FIEGE HEALTHCARE LOGISTICS GMBH profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for FIEGE HEALTHCARE LOGISTICS GMBH's Gliclazide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
FIEGE HEALTHCARE LOGISTICS GMBH
Full Company Profile →
2 products · $2.8M total trade · 2 categories
| GLICLAZIDE SANDOZ 30MG 30 NL GLICLAZIDEMODIFIED RELEASE TABLETS OTHERS-MEDICINE PUT UP FOR RETAIL SALE |
| $73.2K |
| 3 |
| GLICLAZIDE TAB SANDOZ 30MG 60 ES GLICLAZIDE MR TABLETS OTHERS-MEDICINE PUT UP FOR RETAIL SALE | $53.0K | 4 |
| GLICLAZIDE SANDOZ 30MG 30 NL GLICLAZIDE MODIFIED RELEASE TABLETS OTHERS MEDICINE PUT UP FOR RETAIL SALE | $50.0K | 1 |
FIEGE HEALTHCARE LOGISTICS GMBH imports 26 distinct Gliclazide formulations from India. The top formulation is GLICLAZIDE SANDOZ 30MG 30 NL GLICLAZIDE MODIFIED RELEASE TAB with 8 shipments worth $258.1K.
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for FIEGE HEALTHCARE LOGISTICS GMBH.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current order-level data, contact TransData Nexus.